Ranitidine hydrochloride
SIGMA/R101 - solid
CAS Number: 66357-59-3
Empirical Formula (Hill Notation): C13H22N4O3S · HCl
Molecular Weight: 350.86
EC Number: 266-333-0
MDL Number: MFCD00069339
Linear Formula: C13H22N4O3S · HCl
Product Type: Chemical
| color | tan |
| form | solid |
| InChI | 1S/C13H22N4O3S.ClH/c1-14- |
| InChI key | GGWBHVILAJZWKJ-CHHCPSLASA |
| originator | GlaxoSmithKline |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].CNC(NCCSCc1ccc(CN( |
| solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
| H2O: 1.8 mg/mL |
| Application: | Ranitidine hydrochloride has been used as a reference compound for the development and validation of parallel artificial membrane permeability assay (PAMPA). |
| Biochem/physiol Actions: | H2 histamine receptor antagonist; anti-ulcer agent. |
| Biochem/physiol Actions: | Ranitidine is mainly used to treat gastrointestinal impairment instigated by non-steroidal anti-inflammatory drugs (NSAIDs). |
| Features and Benefits: | This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Histamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 g in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |

